GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anebulo Pharmaceuticals Inc (FRA:214) » Definitions » FCF Yield %

Anebulo Pharmaceuticals (FRA:214) FCF Yield % : -12.79 (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Anebulo Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Anebulo Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-8.23 Mil, and Market Cap is €64.92 Mil. Therefore, Anebulo Pharmaceuticals's FCF Yield % for today is -12.79%.

The historical rank and industry rank for Anebulo Pharmaceuticals's FCF Yield % or its related term are showing as below:

FRA:214' s FCF Yield % Range Over the Past 10 Years
Min: -20.6   Med: 0   Max: 0
Current: -12.79


FRA:214's FCF Yield % is ranked better than
53.23% of 1550 companies
in the Biotechnology industry
Industry Median: -14.395 vs FRA:214: -12.79

Anebulo Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


Anebulo Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Anebulo Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anebulo Pharmaceuticals FCF Yield % Chart

Anebulo Pharmaceuticals Annual Data
Trend Jun20 Jun21 Jun22 Jun23
FCF Yield %
- -3.03 -8.47 -16.76

Anebulo Pharmaceuticals Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.37 -19.73 -20.66 -11.35 -7.98

Competitive Comparison of Anebulo Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Anebulo Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anebulo Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anebulo Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Anebulo Pharmaceuticals's FCF Yield % falls into.



Anebulo Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Anebulo Pharmaceuticals's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-8.937 / 53.317056
=-16.76%

Anebulo Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.377 * 4 / 68.982312
=-7.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anebulo Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Anebulo Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Anebulo Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Anebulo Pharmaceuticals (FRA:214) Business Description

Traded in Other Exchanges
Address
1017 Ranch Road 620 South, Suite 107, Lakeway, TX, USA, 78734
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Anebulo Pharmaceuticals (FRA:214) Headlines

No Headlines